| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |